These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39239801)

  • 21. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decongestion (instead of ultrafiltration?).
    Schuermans A; Verbrugge FH
    Curr Opin Cardiol; 2024 May; 39(3):188-195. PubMed ID: 38362936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies.
    Biegus J; Zymlinski R; Siwolowski P; Testani J; Szachniewicz J; Tycińska A; Banasiak W; Halpert A; Levin H; Ponikowski P
    Eur J Heart Fail; 2019 Sep; 21(9):1079-1087. PubMed ID: 31127666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
    Cox ZL; Hung R; Lenihan DJ; Testani JM
    JACC Heart Fail; 2020 Mar; 8(3):157-168. PubMed ID: 31838029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decongestion in Acute Heart Failure-Time to Rethink and Standardize Current Clinical Practice?
    Bilgeri V; Spitaler P; Puelacher C; Messner M; Adukauskaite A; Barbieri F; Bauer A; Senoner T; Dichtl W
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial.
    Cox ZL; Collins SP; Aaron M; Hernandez GA; Iii ATM; Davidson BT; Fowler M; Lindsell CJ; Jr FEH; Jenkins CA; Kampe C; Miller KF; Stubblefield WB; Lindenfeld J
    Am Heart J; 2021 Feb; 232():116-124. PubMed ID: 33144086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editor's Choice-Diuretic resistance in acute heart failure.
    Verbrugge FH
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):379-389. PubMed ID: 29897275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure.
    Martens P; Dupont M; Verbrugge FH; Damman K; Degryse N; Nijst P; Reynders C; Penders J; Tang WHW; Testani J; Mullens W
    JACC Heart Fail; 2019 May; 7(5):404-414. PubMed ID: 31047021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worsening renal function in acute heart failure in the context of diuretic response.
    Emmens JE; Ter Maaten JM; Matsue Y; Figarska SM; Sama IE; Cotter G; Cleland JGF; Davison BA; Felker GM; Givertz MM; Greenberg B; Pang PS; Severin T; Gimpelewicz C; Metra M; Voors AA; Teerlink JR
    Eur J Heart Fail; 2022 Feb; 24(2):365-374. PubMed ID: 34786794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
    Cox ZL; Collins SP; Hernandez GA; McRae AT; Davidson BT; Adams K; Aaron M; Cunningham L; Jenkins CA; Lindsell CJ; Harrell FE; Kampe C; Miller KF; Stubblefield WB; Lindenfeld J
    J Am Coll Cardiol; 2024 Apr; 83(14):1295-1306. PubMed ID: 38569758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic resistance in acute heart failure: proposal for a new urinary sodium-based definition.
    Pellegrino M; Villaschi A; Gasparini G; Maccallini M; Pinto G; Pini D
    Int J Cardiol; 2024 Nov; 415():132456. PubMed ID: 39151483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic Resistance in Heart Failure.
    Gupta R; Testani J; Collins S
    Curr Heart Fail Rep; 2019 Apr; 16(2):57-66. PubMed ID: 30762178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
    Ter Maaten JM; Rao VS; Hanberg JS; Perry Wilson F; Bellumkonda L; Assefa M; Sam Broughton J; D'Ambrosi J; Wilson Tang WH; Damman K; Voors AA; Ellison DH; Testani JM
    Eur J Heart Fail; 2017 Aug; 19(8):1014-1022. PubMed ID: 28105769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of chlorthalidone and spironolactone as additional diuretic therapy in patients with acute heart failure and preserved ejection fraction.
    Llàcer P; Núñez J; García M; Ruiz R; López G; Fabregate M; Fernández C; Croset F; Del Hoyo B; Gomis A; Manzano L
    Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(4):350-355. PubMed ID: 35167653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spot urine sodium as a marker of urine dilution and decongestive abilities in acute heart failure.
    Guzik M; Iwanek G; Fudim M; Zymliński R; Marciniak D; Ponikowski P; Biegus J
    Sci Rep; 2024 Jan; 14(1):1494. PubMed ID: 38233473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure.
    Scatularo CE; Battioni L; Guazzone A; Esperón G; Corsico L; Grancelli HO
    Curr Probl Cardiol; 2024 Aug; 49(8):102674. PubMed ID: 38795800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
    Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
    Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
    ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.
    Galluzzo A; Frea S; Boretto P; Pidello S; Volpe A; Canavosio FG; Golzio PG; Bergerone S; De Ferrari GM
    Clin Res Cardiol; 2020 Oct; 109(10):1251-1259. PubMed ID: 32144493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.